Search for a natural alternative to finasteride and you will land on saw palmetto within minutes. It is sold as capsules, gummies, shampoos, and serums, almost always with the same pitch: it blocks DHT, the hormone that drives pattern hair loss, without a prescription and without the side effects people worry about with finasteride.

The pitch is not entirely wrong. Saw palmetto really does interact with the same enzyme system finasteride targets, and there are human trials showing measurable effects. But the studies are small, the results are modest, and the gap between saw palmetto and the prescription option is larger than supplement marketing tends to admit. Here is an honest walkthrough of the evidence, so you can decide where, if anywhere, it belongs in your routine.

What saw palmetto is and how it might work

Saw palmetto is an extract from the berries of Serenoa repens, a small palm native to the southeastern United States. The extract used in studies is usually a standardized liposterolic (fat-soluble) extract rich in fatty acids such as lauric and myristic acid.

Those fatty acids inhibit 5-alpha-reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT). DHT is the main hormonal driver of androgenetic alopecia in people who are genetically susceptible: it binds to receptors in scalp follicles and gradually miniaturizes them. This is the same enzyme finasteride inhibits, which is why saw palmetto gets called a natural finasteride.

The comparison needs two big asterisks. First, potency: laboratory work consistently shows saw palmetto is a much weaker enzyme inhibitor than finasteride. Finasteride at just 1 mg per day suppresses serum DHT by roughly 70 percent; saw palmetto at typical doses produces a far smaller and less predictable reduction. Second, standardization: finasteride is a single molecule at a precise dose, while supplements vary widely in extract type, fatty acid content, and actual dose delivered. Two bottles both labeled saw palmetto can be very different products.

The evidence, study by study

Prager 2002: the small trial that started it

The first controlled test in hair loss was a randomized, double-blind, placebo-controlled pilot by Prager and colleagues, published in the Journal of Alternative and Complementary Medicine in 2002. Men with mild to moderate androgenetic alopecia took an oral blend containing liposterolic saw palmetto extract and beta-sitosterol. A majority of the treated group was rated as improved, versus roughly one in ten on placebo.

That sounds impressive until you look at the size: only about two dozen participants, and the product was a multi-ingredient blend, so the effect cannot be pinned on saw palmetto alone. It was a genuine positive signal, but a pilot-sized one, and it has never been replicated at scale.

Rossi 2012: the head-to-head with finasteride

The most informative study is still the two-year comparison by Rossi and colleagues, published in the International Journal of Immunopathology and Pharmacology in 2012. One hundred men with mild to moderate androgenetic alopecia took either saw palmetto 320 mg daily or finasteride 1 mg daily for 24 months.

The results draw the clearest picture we have. In the saw palmetto group, 38 percent of men showed an increase in hair growth. In the finasteride group, 68 percent did. Finasteride worked across both the front hairline region and the crown, while saw palmetto helped mainly at the crown, and finasteride improvements were larger. The study was open-label rather than blinded, which is a real limitation, but the direction is consistent with everything else we know: saw palmetto does something, and finasteride does considerably more.

A reasonable reading: roughly one in three men got a visible benefit from saw palmetto over two years, mostly at the vertex, with milder gains than the prescription option.

Wessagowit 2016: the topical study

Wessagowit and colleagues, publishing in the Australasian Journal of Dermatology in 2016, tested a topical Serenoa repens lotion applied to the scalp for 24 weeks in about 50 men with androgenetic alopecia. Hair counts and hair density improved from baseline over the treatment period.

This is the study most topical saw palmetto serums lean on. It is also small, and it lacked a proper placebo comparison, which matters because hair counts can fluctuate seasonally and with measurement technique. It suggests topical delivery is plausible; it does not establish that it works.

Sudeep 2023: the recent placebo-controlled trial

The most rigorous recent data comes from a 16-week randomized, placebo-controlled study by Sudeep and colleagues, published in Clinical, Cosmetic and Investigational Dermatology in 2023. Roughly 80 adults with mild to moderate androgenetic alopecia received a standardized saw palmetto oil, either orally or topically, or placebo.

The oral group reduced hair fall by about 29 percent from baseline and showed a statistically significant drop in serum DHT compared to placebo. The topical group reduced hair fall by about 22 percent. Those are real, measurable effects in a properly controlled design. Keep the scale in mind, though: 16 weeks is short, hair-fall counts are a softer endpoint than terminal hair density, and the study used one specific standardized extract that may not match what is in a given bottle at the store.

The review literature

A 2020 review by Evron and colleagues in Skin Appendage Disorders pulled together the available studies and concluded that around 60 percent of participants across trials saw some improvement in overall hair quality with saw palmetto, but that study quality was too limited to support it as a routine treatment. Subsequent reviews have landed in the same place: consistent small positive signals, no large definitive trial, and no evidence it matches finasteride.

How it compares to the proven options

It helps to place saw palmetto on the ladder of evidence. Finasteride and minoxidil each have decades of large randomized trials and regulatory approval for hair loss. Microneedling combined with minoxidil has a strong randomized trial behind it. Ketoconazole shampoo has a modest but real supporting literature. Saw palmetto sits below all of these: more human data than most supplements can claim, less than any first-line treatment.

That framing suggests who might reasonably consider it. If you cannot or will not take finasteride, whether because of side-effect concerns, a bad prior experience, or personal preference, saw palmetto is one of the few oral options with any controlled evidence of DHT reduction. Just go in with calibrated expectations: in the best head-to-head we have, it helped about half as many men as finasteride, with smaller gains.

What it should not do is displace the treatments with better evidence. A topical minoxidil foundation is still the highest-value non-prescription move for most people:

And if you like the DHT-adjacent angle, ketoconazole shampoo is another over-the-counter step with human data behind it, used two to three times weekly:

If you decide to try it

The studies that showed effects share a few practical details worth copying. Oral dosing in trials was 320 mg per day of a standardized liposterolic extract, taken with food. Cheaper products based on ground whole berry powder at random doses are not what was tested. Look for the extract type and the fatty acid standardization on the label.

Give it a fair window before judging. Hair cycles are slow; the meaningful oral studies ran 16 weeks to two years. Take monthly photos under the same lighting and part your hair the same way, because memory is a terrible instrument for tracking gradual change.

Know the safety profile. Saw palmetto is generally well tolerated, with occasional mild stomach upset or headache. A few cautions are worth flagging: it may have mild antiplatelet effects, so mention it before surgery or if you take blood thinners; it can theoretically influence PSA readings, so tell your doctor you take it before prostate screening; and it should not be used by people who are pregnant or trying to conceive, since interfering with DHT during pregnancy can affect fetal development.

Finally, be careful about stacking it with finasteride expecting extra benefit. They act on the same enzyme, finasteride already inhibits it far more strongly, and there is no evidence the combination adds anything.

The bottom line

Saw palmetto is one of the rare natural hair loss products with real human trials behind it, and those trials point the same direction: a modest, genuine effect for a subset of users, concentrated at the crown, clearly weaker than finasteride. The 2023 placebo-controlled trial strengthens the case that something is happening; nothing in the literature suggests it rivals the first-line treatments.

If you want the most effective plan, the evidence still says: minoxidil as the base, finasteride or another prescription anti-androgen if appropriate for you, and adjuncts like microneedling and ketoconazole shampoo layered on top. Saw palmetto is a defensible fallback for people who have ruled out prescription options, not a substitute for them.

Prescription medications like finasteride affect hormones and are not right for everyone. Talk to a doctor or dermatologist before starting, stopping, or combining hair loss treatments.

This article is for information only and is not medical advice.